http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-333294-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa48a431ce250933eb0fdd7a1caf3f30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-23
filingDate 1997-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08bd89ec89c440da921593e4626c18e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e804e80ff9dde59cc4c215660072b93c
publicationDate 2000-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NZ-333294-A
titleOfInvention Non-aqueous polar aprotic (DMSO or DMF) peptide formulations
abstract The specification describes stable non-aqueous polar aprotic formulations of peptide compounds. The non-aqueous polar aprotic solvent is preferably DMSO and the peptide is leuprolide, LHRH, nafarelin or goserelin. They may be stored at elevated temperatures for long periods of time and are especially useful in implantable delivery devices for long term delivery of drug.
priorityDate 1996-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590905
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44354963
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25077405
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423271027
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426262665
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408786858
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311128
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27429
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID657181

Total number of triples: 41.